Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and α-tocopherol

Annals of Hematology

Volumn 72, Issue 4, 1996, Pages 237-244

  Ganser, A ^a,e   Maurer, A ^a   Contzen, C ^a   Seipelt, G ^a   Ottmann, O G ^a   Schadeck Gressel, C ^b   Kolbe, K ^d   Haas, R ^c   Zander, C ^a   Reutzel, R ^a   Hoelzer, D ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Johannes Hospital   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

All trans retinoic acid; Erythropoietin; Granulocyte colony stimulating factor; ICAM 1; Myelodysplastic syndrome; Soluble IL 2 receptor; TNF receptor; Transferrin receptor; Tumor necrosis factor

Indexed keywords

ALPHA TOCOPHEROL; CYTARABINE; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLAST CELL; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATITIS; DRUG BLOOD LEVEL; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; HEMATOPOIESIS; HUMAN; HYPERTENSION; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; TRANSFUSION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; BONE MARROW; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRETINOIN; VITAMIN E;

EID: 0029865715     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050166     Document Type: Article

References (34)

1. Sachs L (1990) The control of growth and differentiation in normal and leukemic blood cells. Cancer 65:2196-2206
2. Ohmori S, Ohmori M, Yamagishi M, Okuma M (1993) MDS-macrophage-derived inhibitory activity on myelopoiesis of MDS abnormal clones. Br J Haematol 83:388-391
3. Ganser A, Hoelzer D (1992) Treatment of myelodysplastic syndromes with hematopoietic growth factors. Hematol Oncol Clin North Am 6:607-618
4. Kobayashi Y, Okabe T, Ozawa K (1989) Treatment of myelodysplastic syndromes with human granulocyte colony-stimulating factor: a preliminary report. Am J Med 86:178-182
5. Negrin RS, Haeubner DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL (1990) Maintenance therapy of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulatins factor. Blood 76:36-43
6. Hellström-Lindberg E (1995) Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. Br J Haematol 89:67-71
7. Negrin RS, Stein R, Vardiman J, Doherty K, Comwell J, Krantz S, Greenberg PL (1993) Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulatins factor in combination with erythropoietin. Blood 82:737-743
8. Hellström-Lindberg E, Birgegard G, Carlsson M. Dahl IM, Grimsfors G, Winqvist I, Öst A (1993) A combination of granulocyte colony-stimulating factor and erythropoietin may synergistically improve the anaemia in patients with myelodysplastic syndromes. Leuk Lymphoma 11:221-228
9. Imamura M, Kobayashi M, Kobayashi S, Yoshida K, Mikuni C, Ishikawa Y, Matsumoto S, Sakamaki S, Niitsu Y, Hinoda Y, Yachi A, T, Kudoh T, Chiba S, Kasai M, Oka T, Okuno A, Maekawa I. Sakurada K, Miyazaki T (1994) Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes. Ann Hematol 68:163-166
10. Bollag W, Holdener EE (1992) Retinoids in cancer prevention and therapy. Ann Oncol 3:513-526
11. Visani G, Cenacchi A, Tosi P, Finelli C (1992) All-trans retinoic acid improves erythropoiesis in myelodysplastic syndromes: a case report. Br J Haematol 81:444-448
12. Ohno R, Naoe T, Hirano M, Kobayashi M, Hirai H, Tubaki K, Oh H (1993) Treatment of myelodysplastic syndromes with all-trans retinoic acid. Blood 81:1152-1154
13. Aul C, Runde V, Gattermann N (1993) All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study. Blood 82:1967-1974
14. Kurzrock R, Estey E, Talpaz M (1993) All-trans retinoic acid: Tolerance and biologic effects in myelodysplastic syndromes. J Clin Oncol 11:1489-1496
15. Douer D, Koeffler HP (1982) Retinoic acid enhances growth of human early erythroid progenitor cells in-vitro. J Clin Invest 69:1039-1041
16. Correa PN, Axelrad A (1992) Retinyl acetate and all-transretinoic acid enhance erythroid colony formation in vitro by circulating human progenitors in an improved serum-free medium Int J Cell Cloning 10:286-291
17. Ganser A, Seipelt G, Verbeeck W, Ottmann OG, Maurer A, Kolbe K, Hess U, Reutzel R, Wórmann B, Hiddemann W, Hoelzer D (1994) Effect of combination therapy with all-trans retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes. Leukemia 8:369-375
18. Sakashita A, Nakamaki T, Tsuruoka N, Honma Y, Hozumi M (1991) Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor acts with retinoic id to form functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells. Leukemia 5:26-31
19. Valtieri M, Boccoli G, Testa U, Barletta C. Peschle C (1991) Two-step differentiation of AML 193 leukemic line: terminal maturation is induced by positive interaction of retinoic acid with granulocyte colony-stimulating factor (CSF) and vitamin D3 with monocyte CSF. Blood 77:1804-1812
20. Geißler GR, Ganser A, Ottmann OG, Gute P, Morawetz A, Guba P, Helm EB, Hoelzer D (1994) In vitro improvement of bone marrow-derived hematopoietic colony formation in HIV-positive patients by alpha-tocopherol and erythropoietin. Eur J Haematol 53:201-206
21. Besa EC, Abraham IL, Bartholomew MJ, Hyzninski M, Nowell PC (1990) Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndromes and decreased toxocity with addition of alpha-tocopherol. Am J Med 89:739-747
22. Miller AB, Hoogstraaten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:201-206
23. Beguin Y, Clemons GK, Pootrakul P, Fillet G (1993) Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 81:1067-1076
24. Bowen DT, Culligan D, Beguin Y, Kendall R, Willis N (1994) Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia 8:151-155
25. Maurer AB, Ganser A, Seipelt G, Ottmann OG, Mentzel U, Geissler GR, Hoelzer D (1995) Changes in erythroid progenitor cell and accessory cell compartments in patients with myelodysplastic syndromes during treatment with all-trans retinoic acid and haematopoietic growth factors. Br J Haematol
26. Nakajima H, Kizaki M, Sonoda A, Mori S, Harigaya K, Ikeda Y (1994) Retinoids (all-trans and 9-cis retinoic acid) stimulate production of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by human bone marrow stromal cells. Blood 84:4107-4115
27. Beguin Y, Clemons GK, Pootrakul P, Fillet G (1993) Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 81:1067-1076
28. Bowen DT, Culligan D, Beguin Y, Kendall R, Willis N (1994) Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia 8:151-155
29. Verhoef GE, De Schouwer P, Ceuppens JL, Van Damme J, Goossens W, Boogaerts MA (1992) Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 6:1268-1272
30. Seipelt G, Ganser A, Duranceyk H, Maurer A, Ottmann OG, Hoelzer D (1993) Induction of TNF-α in patients with myelodysplastic svndromes undergoing treatment with interleukin-3. Br J Haematol 84:749-751
31. Völkers B, Ganser A, Greher J, Stella C, Hoelzer D (1989) Effect of recombinant tumor necrosis factor on human hematopoietic progenitor cells. Onkologie 12:109-115
32. Grande A, Manfredini R, Tagliafico E, Ballestri R, Pizzanelli M, Papa S, Zucchini P, Bonsi L, Bagnara G, Torelli U, Ferrari S (1995) All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. Exp Hematol 23:117-125
33. Maurer AB, Ganser A, Buhl R, Seipelt G, Ottmann OG, Mentzel U, Geissler RG, Hoelzer D (1993) Restoration of impaired cytokine secretion from patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3. Leukemia 7:189-195
34. Turpin J, Mehta K, Blick M, Hester JP. Lopez-Berestein G (1990) Effect of retinoids on the release and gene expression of tumor necrosis factor-α in human peripheral blood monocytes. J Leuk Biol 48.444-450